World Journal of Clinical Cases - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 13

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

1303

Figures (1-9)

316

Tables (1-2)

296

Sum=1996

Publishing Process of This Article

Item

Count

Browse

Download

365

Sum=461

May 6, 2024 (publication date) through Jun 12, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Lu SH, Yu YF, Dai SS, Hu YQ, Liu JH. Efficacy and safety of Yangxinshi tablet for chronic heart failure: A systematic review and meta-analysis. World J Clin Cases 2024; 12(13): 2218-2230 [PMID: 38808352 DOI: 10.12998/wjcc.v12.i13.2218]
URL:	https://www.wjgnet.com/2307-8960/full/v12/i13/2218.htm

Number	Citing Articles
1	Binmei Zhang, Jingxiu Hou, Li Dong, Man Sun, Ying Dong, Yumei Dong. Administration with Yangxinshi ameliorates the progression of atrial fibrillation by affecting atrial remodeling and oxidative stress via the activation of the PI3K/AKT signaling. Cytotechnology 2025; 77(3) doi: 10.1007/s10616-025-00778-8